References:
Bedlack RS, Wicks P, Vaughan T, et al. Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):285-293. View abstract.
Dai G, Zhang P, Ye P, et al. The chemopreventive peptide lunasin inhibits d-galactose-induced experimental cataract in rats. Protein Pept Lett 2016; Published online ahead of print. View abstract.
de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage. Peptides 2009;30(12):2388-98. View abstract.
Dia VP, Torres S, de Lumen BO, et al. Presence of lunasin in plasma of men after soy protein consumption. J Agric Food Chem 2009;57(4):1260-6. View abstract.
Dzirkale Z, Rumaks J, Svirskis S, et al. Lunasin-induced behavioural effects in mice: focus on the dopaminergic system. Behav Brain Res 2013;256:5-9. View abstract.
Fernández-Tomé S, Indiano-Romacho P, Mora-Gutiérrez I, et al. Lunasin peptide is a modulator of the immune response in the human gastrointestinal tract. Mol Nutr Food Res. 2021 Jun;65(12):e2001034. View abstract.
Galvez AF. Identification of lunasin as the active component in soy protein responsible for reducing LDL cholesterol and risk of cardiovascular disease [abstract]. Circulation 2012;126:A10693.
Haddad Tabrizi S, Haddad E, Rajaram S, Oda K, Kaur A, Sabaté J. The effect of soybean lunasin on cardiometabolic risk factors: A randomized clinical trial. Subst Use Misuse. 2019;54(9):1530-1540. View abstract.
Hernandez-Ledesma B, Hsieh CC, de Lumen BO. Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun 2009;390(3):803-8. View abstract.
Hsieh CC, Hernandez-Ledesma B, Jeong HJ, et al. Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One 2010;5(1):e8890. View abstract.
Hsieh CC, Wang YF, Lin PY, Peng SH, Chou MJ. Seed peptide lunasin ameliorates obesity-induced inflammation and regulates immune responses in C57BL/6J mice fed high-fat diet. Food Chem Toxicol. 2021 Jan;147:111908. View abstract.
Jeong HJ, Jeong JB, Kim DS, de Lumen BO. Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J Agric Food Chem 2007;55(3):632-7. View abstract.
Jia S, Zhang S, Yuan H, Chen N. Lunasin inhibits cell proliferation via apoptosis and reduces the production of proinflammatory cytokines in cultured rheumatoid arthritis synovial fibroblasts. Biomed Res Int 2015;2015:346839. View abstract.
Jiang Q, Pan Y, Cheng Y, et al. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-kB signaling pathways. Oncol Rep 2016;Published online ahead of print. View abstract.
Liu J, Jia SH, Kirberger M, Chen N. Lunasin as a promising health-beneficial peptide. Eur Rev Med Pharmacol Sci 2014;18(14):2070-5. View abstract.
Lule VK, Garg S, Pophaly SD, et al. Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide. J Food Sci 2015;80(3):R485-94. View abstract.
Odani S, Koide T, Ono T. Amino acid sequence of a soybean (Glycine max) seed polypeptide having a poly(L-aspartic acid) structure. J Biol Chem 1987;262(22):10502-5. View abstract.
Tung CY, Lewis DE, Han L, et al. Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant. Vaccine 2014;32(42):5411-9. View abstract.
Yang X, Zhu J, Tung CY, et al. Lunasin alleviates allergic airway inflammation while increasing antigen-specific Tregs. PLoS One 2015;10(2):e0115330. View abstract.